Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study.
Miri S, Rosendaal FR, Kavakli K, Eshghi P, Moghaddam SM, Scardo S, Habibpanah B, Elalfy M, Halimeh S, Nicolò G, Gökçebay D, Özbek N, Celkan T, Mohammadi A, Karimi M, Shahsavani A, Yılmaz B, Albayrak C, Gunes B, Kaya Z, Ay Y, Akbayram S, Sarper N, Mannucci PM, Peyvandi F; PUP-SWITCH Study Group.
Miri S, et al.
Res Pract Thromb Haemost. 2024 Oct 18;8(8):102595. doi: 10.1016/j.rpth.2024.102595. eCollection 2024 Nov.
Res Pract Thromb Haemost. 2024.
PMID: 39649130
Free PMC article.